Background: Cardiovascular autonomic neuropathy is a major complication in patients with diabetes mellitus (DM), and baroreflex sensitivity (BRS) reportedly can predict cardiovascular prognosis in type 2 DM patients. The hypothesis that cardiovascular events are associated with gender differences in BRS was tested in the present study.
utonomic imbalance, characterized by increased sympathetic activity and/or decreased parasympathetic activity, is tightly related to cardiovascular mortality. Among several autonomic markers, baroreflex sensitivity (BRS) has predicted cardiac mortality in patients with previous myocardial infarction (MI). [1] [2] [3] [4] [5] The ATRAMI study demonstrated that, independent from left ventricular ejection fraction, depressed BRS was an independent predictor for cardiac mortality, 1 and impaired BRS has been also associated with increased long-term mortality after acute ischemic stroke. 6 In our series of clinical studies investigating BRS using the phenylephrine method in patients with type 2 diabetes mellitus (DM) without structural heart disease, 7-11 the presence of essential hypertension, 7 microalbuminuria, 8 high levels of high-sensitivity C-reactive protein 9 or brain natriuretic peptide, 10 or hypoadiponectinemia 11 have been associated with low levels of BRS. Abdel-Rahman et al first reported in healthy young subjects that females had less sensitive baroreflex control of heart rate than males, 12 and several studies have reported on gender-related differences regarding the baroreflex response. 12-17 However, it remains unclear whether there is a gender difference in BRS as a predictive value, so the hypothesis that cardiovascular events are associated with gender differences in BRS was tested in Japanese type 2 DM patients without structural heart disease.
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Patient Selection
A total of 210 patients with type 2 DM who were admitted to Oita University Hospital from 1998 to 2004 for blood glucose control were recruited. Type 2 DM was defined as a fasting plasma glucose concentration ≥126 mg/dl, a 2-h Gender Difference in BRS and MACCE plasma glucose concentration following a 75 g oral glucose load ≥200 mg/dl, or the self-reported use of antidiabetic medication. 18 None of the patients had organic heart disease as determined by physical examination, chest X-ray, 12-lead ECG, echocardiography, and 201 thallium cardiac scintigraphy. Myocardial ischemia was excluded by treadmill exercise ECG testing. Essential hypertension was defined as diastolic blood pressure (BP) ≥90 mmHg, systolic BP ≥140 mmHg or self-reported use of antihypertensive medication. 19 Patients treated with α-or β-adrenergic blocking agents, antiplatelet agents or with macroalbuminuria (≥500 mg/day) or abnormal plasma creatinine concentrations (≥1.2 mg/dl) were also excluded from the study. Dyslipidemia was defined as fasting triglycerides >200 mg/dl, or high-density lipoprotein (HDL) cholesterol ≤45 mg/dl in females and ≤35 mg/dl in males. 19 Hyperuricemia was defined as uric acid >6.0 mg/dl in females or >7.0 mg/dl in males. 20 Chronic kidney disease (CKD) was defined as an estimated glomerular filtration rate (eGFR) <60 ml · min -1 · 1.73 m -2 . 21 Patients with an eGFR <30 ml · min -1 · 1.73 m -2 were excluded. This investigation was conducted according to the principles expressed in the Declaration of Helsinki. Prior informed consent in terms of gathering BRS measurements was obtained from all patients, and the study protocol was approved by the institutional review board of Oita University. Of the total 210 patients enrolled, we obtained accurate follow-up information for 3-10 years (mean 4.7 years) from 185 patients (94 males, 91 females; mean age 58±12 years, range 31-83 years).
BRS Measurement
For the BRS assessment, all subjects were studied between 9:00 and 11:00 AM while supine in a quiet room. 7 A catheter was inserted into the right cubital vein, and arterial BP was recorded noninvasively using tonometry (Jentow-7700; Nihon Colin, Komaki, Japan). 7 Arterial BP and 12-lead ECG were monitored simultaneously. Data were stored in a PCM data recorder (RD-200T; TEAC, Tokyo, Japan). After an interval of 30 min to allow the patient's condition to stabilize, the patient was asked to breathe at a rate of 15 breaths/min using a metronome. BRS was assessed using the phenylephrine method. 1 Phenylephrine (2-3 μg/kg) was injected over 15 s to increase systolic BP by 15-40 mmHg. BRS was calculated as the slope of the linear regression line relating the systolic BP changes to the RR interval changes. Regression lines with more than 20 data points and a correlation coefficient (r) >0.8 were accepted for analysis. The mean of the 2 slope values was taken as the BRS value. BRS was considered depressed if it was <6 ms/mmHg. 1,22
Follow-up
Most of the follow-up for patients occurred at Oita University Hospital. Information was also obtained for those patients whose follow-up was performed by a general practitioner or who were hospitalized in other departments. For the patients who died, the cause of death was documented with the help of the patients' family and general practitioner.
The endpoint was defined as the appearance of a major adverse cardiac and cerebrovascular event (MACCE), which included cardiovascular mortality, nonfatal MI, coronary revascularization through angioplasty or bypass, stroke and congestive heart failure requiring admission. Using this combined criterion, only the first event was taken into account in the statistical analysis.
Statistical Analysis
Data are presented as mean ± SD. The chi-square test was used for categorical variables, and the analysis of variance (ANOVA) test was used for continuous variables. Differences between 2 groups were analyzed by Student's t-test. One-way ANOVA followed by Tukey-Kramer honestly significant difference test was used to test differences among the preserved BRS males, the depressed BRS males, the preserved BRS females, and the depressed BRS females. Kaplan-Meier MACCE-free analysis was used to compare MACCE-free times among the 4 groups. To test for differences between the resulting curves, the log-rank test was used. 
Results
Patients' Characteristics
There were no significant differences in age or severity and duration of DM between the male and female patients. When compared to males, the BRS value in female patients was significantly lower (9.21±6.0 vs. 5.90±5.1 ms/mmHg, P<0.0001). Baseline characteristics of the 4 groups (preserved BRS males, depressed BRS males, preserved BRS females, depressed BRS females) are shown in Table 1 . Comparing all male patients with all female patients, there were no differences in age (58±11 vs. 58±12 years), duration of DM (10±9 vs. 9±7 years) or systolic BP (125±20 vs. 129±20 mmHg). Regarding the differences among the 4 groups, the mean age was higher in the depressed BRS female patients than in the preserved BRS females (P<0.05). The duration of DM was longer in the depressed BRS females than in the preserved BRS females (P<0.05). Among the 4 groups, there was no difference in the percentage of patients treated with angiotensin II receptor blockers (ARBs), angiotensin converting enzyme inhibitors (ACEI), calcium channel blockers (CCB) or statins. Systolic BP was higher in the depressed BRS females than in the preserved BRS males and females (P<0.0005). However, HDL cholesterol was lower in the depressed BRS males than in the preserved BRS females and the depressed BRS females (P< 0.005). Uric acid was higher in the preserved and depressed BRS males than in the depressed BRS females (P<0.01). The eGFR was lower in the depressed BRS males than in the preserved BRS females (P<0.05). BRS was lower in the depressed males and females than in the preserved males and females (P<0.0001). MI, myocardial infarction. Other abbreviation see in Table 1 . Tables 1,3 . Gender Difference in BRS and MACCE
Patients' Outcomes
During follow-up, 8 patients died (4.3%): 4 were cardiovascular deaths and 4 were attributed to non-cardiovascular causes. All-cause mortality rates were not significantly different among the 4 groups. There were no significantly differences in the total cardiovascular mortalities of the 4 groups: 0% (0/63) in the preserved BRS males, 3.2% (1/31) in the depressed BRS males, 2.8% (1/36) in the preserved BRS females, and 3.6% (2/55) in the depressed BRS females.
Univariate and Multivariate Predictors of MACCE
During follow-up, 20 patients presented with a MACCE (10.8%) and of these 20 MACCEs, 4 were cardiovascular deaths, 3 were nonfatal MI, 4 were coronary revascularizations, 5 were strokes, and 4 were congestive heart failure ( Table 2) . MACCEs occurred more frequently in the depressed BRS females (25.5%) than in the preserved BRS males (3.2%), the depressed BRS males (6.5%) or the preserved BRS females (5.6%) (P<0.001). Results of univariate and multivariate Cox proportional hazards regression analysis of MACCE in males and females are presented in Tables 3,4 . In male patients, univariate analysis revealed no significant factors associated with MACCE (Table 3) , whereas in female patients, body mass index ≥25, the prevalence of hypertension, dyslipidemia, hyperuricemia, CKD and depressed BRS were associated with MACCE ( Table 4 ). In the multivariate analysis using risk factors including age, body mass index ≥25, hypertension, dyslipidemia, hyperuricemia, CKD, smoking status, hemoglobin A1c, and depressed BRS, both hyperuricemia (HR 2.61, 95%CI 1.43-4.92, P=0.0019) and depressed BRS (HR 3.26, 95%CI 1.50-9.00, P=0.0018) independently predicted the incidence of MACCE ( Table 4) .
Kaplan-Meier MACE-Free Estimation
The MACCE-free ratio as evaluated by Kaplan-Meier analysis was significantly lower in the depressed BRS females than in the other groups (log-rank 15.63, P=0.0013) (Figure) .
Discussion
In the present study, 185 Japanese type 2 DM patients were followed for a mean period of 4.7 years, and MACCE occurred in 20 of them. The most important finding is that a depressed BRS value can accurately predict cardiovascular events, especially in female patients with type 2 DM. To the best of our knowledge, this report is the first to demonstrate a gender difference in the ability of the BRS value obtained using the phenylephrine method to predict long-term cardiac and cerebrovascular events in Japanese type 2 DM patients who do not have structural heart disease/severe complications. The MACCE-free ratio as evaluated by Kaplan-Meier analysis was significantly lower in the depressed BRS female group than in the other 3 groups. Abdel-Rahman et al first reported in healthy young subjects that females had a smaller BRS value than males, 12 and their finding that the baroreceptor reflex control of heart rate was significantly lower in females compared with the values obtained from males of similar age and basal BP suggested a weaker vagal response in females. Because the heart rate reduction in response to abrupt pressor stimuli mainly reflects the activity of the vagal component, their findings suggest that the cardiac vagal component plays a substantially smaller role in baroreflex-mediated bradycardia in females. Our result that the BRS value in female patients was significantly lower than in male patients is consistent with that finding. Laitinen et al reported 13 that females had lower BRS values and greater inter-individual variation than did males, but the slopes of the BRS -age regression lines in females and males did not differ. However, compared with males, there was a parallel downward shift of the BRS -age regression lines in females. It has been reported that 24% of middle-aged and older healthy females have a markedly depressed BRS (<3 ms/mmHg), which has been associated with a high risk of arrhythmias in postinfarction patients. 2, 3 Huikuri et al 23 suggested that the sex hormones could play a role in the gender-related difference in BRS. In their study, BRS was higher in postmenopausal women taking hormonal replacement therapy than in those who did not. Similarly, it has been previously reported that baroreflex-mediated control of heart rate is altered during the normal menstrual cycle. 24 The baroreflex-mediated bradycardic response was augmented during the preovulatory phase and appeared to correlate with the plasma estradiol concentration, whereas baroreflex-mediated tachycardia was augmented during the early follicular phase. Significant correlations were observed between plasma estradiol concentrations and BRS assessed by the phenylephrine method and the Valsalva maneuver. 24 Sevre et al demonstrated a significantly lower BRS in hypertensive subjects than in normotensive controls. 15 Moreover, the reduction in BRS was most pronounced in the female group and did not reach statistical significance in men. BRS was also reduced in hypertensive women compared with hypertensive men. Previous studies have proposed that female sex hormones modeled the arterial layers, which are crucial to the arterial BP buffer capacity and hence BP variability and BRS. 25-27 These findings imply that hypertensive women are more susceptible to cardiac events and arrhythmias than hypertensive men. 15 During the past several decades, knowledge regarding gender differences in coronary heart disease has been emerging. Annual ischemic heart disease (IHD) population statistics continue to report a greater number of deaths for females than males. 28 Diabetic females have significantly greater rates of IHD mortality than diabetic males, 29,30 and a 3.3-fold IHD risk compared with nondiabetic females. 31 The 30-year trends reveal marked cardiovascular disease mortality reduction for diabetic males but not for diabetic females. 32 Our findings are compatible with previous results from INTERHEART, a large case -control study of more than 15,000 cases of acute MI, which concluded that DM was a more significant coronary risk among females than it was among males. 33 Huxley et al explained why DM has a greater adverse affect in females than in males. According to their analysis, DM induces a more unfavorable cardiovascular risk profile among females. They found that women with DM not only have significantly higher levels of BP and lipids than males with DM but that the difference in the levels among people with and without DM was significant greater in females than it was in males. 34 In our analysis, total cholesterol, low-density lipoprotein cholesterol, and HbA1c were significantly higher in females than in males, but BP was no different between genders. Alternatively, the greater coronary risk associated with DM seen in females may reflect a treatment bias that favors males. A recent study found that males with DM or established cardiovascular disease are more likely to received aspirin, statins, or antihypertensive drugs than are females. 35 Leslee et al hypothesized that females experienced more adverse outcomes compared with males because atherosclerotic IHD remains the current problem for therapeutic strategies. 28 Recent data from the Euro Heart Survey of Stable Angina reported that females with IHD were less likely to receive coronary revascularization. One reason proposed for the lower rates of revascularization in females include the relatively poorer outcome and higher rates of complications in females undergoing either coronary bypass graft surgery or percutaneous revascularization. 36 When compared to the preserved BRS female group, the depressed BRS females had a significantly longer duration of DM, higher BP, and were older. These factors may influence our observation that MACCE developed more frequently in the depressed BRS females than in the preserved BRS females. However, looking at the differences between depressed BRS males and depressed BRS females, there was no significant difference with respect to age, BP or duration of DM. The eGFR was lower in the depressed BRS males than in the preserved BRS females in this study. CKD patients defined as having reduced GFR have an increased risk of cardiovascular disease, 37 and it has been also reported that CKD was associated with MACCE in young Japanese coronary artery disease patients. 38 Although our analysis did not extract the presence of CKD as a risk for MACCE, the effects of renal function, as provided by eGFR, on cardiovascular autonomic function and prognosis should be further evaluated.
Study Limitations
First, because we enrolled patients without severe complications, the incidence of MACCE was small, which might make it difficult to analyze the data. Conversely, most of the patients with preserved BRS were free from MACE. Thus, compared to the positive predictive value of depressed BRS (17.6%), the negative predictive value of preserved BRS (96.0%) may be more clinically relevant. Second, clinical manifestations of diabetic autonomic neuropathy involve many systems, including cardiovascular, gastrointestinal, genitourinary, metabolic, sudomotor, and papillary. Because we did not quantitatively evaluate other autonomic neuropathies, their association with BRS remains unclear. Third, as shown in Table 1 , there were significant differences, with respect to age, DM duration, systolic BP, HDL cholesterol, uric acid, and eGFR, among the 4 groups. All these factors might influence the BRS value. In fact, it has been established that increased arterial BP impairs BRS. 39 Finally, we discussed cardiovascular autonomic neuropathy from the viewpoints of BRS, the arm of parasympathetic activity. Sympathetic abnormalities may be also involved, which should be evaluated in future studies using cardiac 123 I-metaiodobenzylguanidine myocardial scintigraphy. 7-11 Fourth, we could not evaluate the effects of the extent of changes in the patients' diabetic condition (ie, levels of plasma glucose and HbA1c) on BRS and MACCE. Fifth, cardiovascular drugs, particularly ARB, ACEI, CCB and statin may be beneficial in improving BRS, which needs to be further investigated. Finally, the cut-off value of the BRS should be defined differently for each gender. We set it at 6 ms/mmHg. However, in fact, the cut-off line from analysis of the receiveroperator characteristics curve was 5.84 ms/mmHg in females and 2.51 ms/mmHg in males.
Conclusion
Our findings demonstrated that depressed BRS value can accurately predict cardiac cerebrovascular events, especially in female patients with type 2 DM. Once diabetic, a female who develops an impaired BRS has a worse prognosis than similar male. Intensive management and/or therapy may be needed in this population.
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